Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites
暂无分享,去创建一个
F. Pasquier | C. Broeckhoven | K. Sleegers | S. Engelborghs | K. Bettens | J. Lambert | P. Amouyel | M. Cruts | N. Brouwers | C. van Broeckhoven | R. Vandenberghe | P. Deyn | P. De Deyn | F Pasquier | C. Van Cauwenberghe | N Brouwers | C Van Cauwenberghe | S Engelborghs | J-C Lambert | K Bettens | N Le Bastard | A Gil Montoya | K Peeters | M Mattheijssens | R Vandenberghe | P P De Deyn | M Cruts | P Amouyel | K Sleegers | C Van Broeckhoven | N. Bastard | K. Peeters | M. Mattheijssens | C. V. Cauwenberghe | N. Le Bastard | F. Pasquier | A. Montoya | Rik Vandenberghe | Maria Mattheijssens
[1] S. Gaudieri,et al. Amino Acid Patterns Within Short Consensus Repeats Define Conserved Duplicons Shared by Genes of the RCA Complex , 2004, Journal of Molecular Evolution.
[2] Rena Li,et al. Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes , 2006, Neurobiology of Aging.
[3] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[4] D. Fearon,et al. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis , 1988, The Journal of experimental medicine.
[5] Jinko Graham,et al. LDheatmap: An R Function for Graphical Display of Pairwise Linkage Disequilibria Between Single Nucleotide Polymorphisms , 2006 .
[6] D. Fearon,et al. Genetic regulation of a structural polymorphism of human C3b receptor. , 1983, The Journal of clinical investigation.
[7] R. Khera,et al. Complement Receptor 1: Disease associations and therapeutic implications , 2008, Molecular Immunology.
[8] P. Tam. The International HapMap Consortium. The International HapMap Project (Co-PI of Hong Kong Centre which responsible for 2.5% of genome) , 2003 .
[9] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[10] B. Bradt,et al. Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide , 1998, The Journal of experimental medicine.
[11] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[12] D. Fearon,et al. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele , 1989, The Journal of experimental medicine.
[13] J. Lewis,et al. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. , 1998, Clinical immunology and immunopathology.
[14] D. Fearon,et al. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins , 1987, The Journal of experimental medicine.
[15] J. Atkinson,et al. Polymorphism of human erythrocyte C3b/C4b receptor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. van Broeckhoven,et al. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. , 2006, Neurobiology of aging.
[17] Jun Zhou,et al. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease , 2008, Journal of neurochemistry.
[18] John D Lambris,et al. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] Jun Zhou,et al. Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease , 2004, The Journal of Neuroscience.
[20] F. Pasquier,et al. A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.
[21] P. Mcgeer,et al. Complement activation by beta-amyloid in Alzheimer disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] W. Scheper,et al. The significance of neuroinflammation in understanding Alzheimer’s disease , 2006, Journal of Neural Transmission.
[23] J. Rogers,et al. Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide , 1997, Journal of neurochemistry.
[24] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[25] K. Sleegers,et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. , 2006, Brain : a journal of neurology.
[26] F. Speleman,et al. Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma , 2010, BMC Genomics.
[27] P. Deyn,et al. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia , 2008, Neurobiology of Aging.
[28] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[29] Simon Fraser,et al. LDheatmap: An R Function for Graphical Display of Pairwise Linkage Disequilibria Between Single Nucleotide Polymorphisms , 2006 .
[30] D. Schaid,et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.
[31] S. DeKosky,et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease , 2009, Molecular Psychiatry.
[32] Harvard Medicalschool. Demonstration ofLong Homologous Repeating Domains That Are Composed of the Short Consensus Repeats Characteristicof C3/C4 Binding Proteins , 1987 .
[33] C. Lemere,et al. Complement C3 Deficiency Leads to Accelerated Amyloid β Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice , 2008, The Journal of Neuroscience.
[34] P. Deyn,et al. Dose dependent effect of APOE ɛ4 on behavioral symptoms in frontal lobe dementia , 2006, Neurobiology of Aging.
[35] J. Atkinson,et al. Structure–function relationships of complement receptor type 1 , 2001, Immunological reviews.
[36] Xavier Estivill,et al. Accounting for uncertainty when assessing association between copy number and disease: a latent class model , 2009, BMC Bioinformatics.
[37] K. Sleegers,et al. Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. , 2010, Journal of Alzheimer's disease : JAD.
[38] Philippe Amouyel,et al. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. , 2010, Trends in genetics : TIG.
[39] W. Wong,et al. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function. , 1991, Journal of immunology.
[40] P. Mcgeer,et al. Inflammation, the complement system and the diseases of aging , 2005, Neurobiology of Aging.
[41] C. Broeckhoven,et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.
[42] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[43] Wen-chao Song,et al. Complement and its role in innate and adaptive immune responses , 2010, Cell Research.